Hosted on MSN11mon
Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's DataWAIS-IV is the most advanced adult measure of cognitive ability. Dalzanemdor (SAGE-718) was generally well-tolerated, and no new safety signals were observed. 48 participants experienced treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback